Healthcare · Drug Manufacturers - General
Latest call day: 2026-10-23 · full consensus board · graded history
Price (daily close, 2026-10-23)
Trailing returns (daily closes)
Today's calls AI
| Pharma & Managed Care · Quality | UP 100% | Quality — operating margin plus revenue growth. LLY ranks #1 of 13 in Pharma & Managed Care (100% bullish percentile), so the agent calls it UP for the next session. |
| Pharma & Managed Care · Bollinger Reversion | DOWN 92% | Bollinger Reversion — fade moves outside the bands. LLY ranks #6 of 13 in Pharma & Managed Care (92% bearish percentile), so the agent calls it DOWN for the next session. |
| Pharma & Managed Care · Breakout | UP 92% | Breakout — pushing above the prior channel high. LLY ranks #2 of 13 in Pharma & Managed Care (92% bullish percentile, signal +1.8%), so the agent calls it UP for the next session. |
| Pharma & Managed Care · Donchian | UP 83% | Donchian — position within the Donchian channel. LLY ranks #3 of 13 in Pharma & Managed Care (83% bullish percentile), so the agent calls it UP for the next session. |
| Pharma & Managed Care · MACD | UP 83% | MACD — MACD histogram momentum crossover. LLY ranks #3 of 13 in Pharma & Managed Care (83% bullish percentile), so the agent calls it UP for the next session. |
| Pharma & Managed Care · Mean-Reversion | DOWN 75% | Mean-Reversion — contrarian on the trailing return. LLY ranks #8 of 13 in Pharma & Managed Care (75% bearish percentile, recent move +4.4%, fading it), so the agent calls it DOWN for the next session. |
| Pharma & Managed Care · Long-Term Reversal | UP 8% | Long-Term Reversal — year-long losers rebound. LLY ranks #12 of 13 in Pharma & Managed Care (8% bullish percentile, signal -64.5%), so the agent calls it UP for the next session. |
Best agents on LLY (graded record)
| Pharma & Managed Care · Dual Momentum | 75% | 3/4 correct | DOWN |
| Pharma & Managed Care · Volume Thrust | 65% | 17/26 correct | UP |
| Pharma & Managed Care · MACD | 64% | 30/47 correct | UP |
| Pharma & Managed Care · OBV Trend | 61% | 25/41 correct | UP |
| Pharma & Managed Care · Donchian | 59% | 22/37 correct | UP |
| Pharma & Managed Care · Momentum | 59% | 27/46 correct | UP |
| Pharma & Managed Care · Vol-Adjusted Momentum | 54% | 14/26 correct | UP |
| Pharma & Managed Care · Breakout | 53% | 32/60 correct | UP |
| Pharma & Managed Care · Long-Term Reversal | 52% | 42/80 correct | UP |
| Pharma & Managed Care · Relative Strength | 52% | 14/27 correct | UP |
Recent news
| 2026-10-24 | Weight-Loss Drugs Are Coming for Beer, Heineken Admits Privately · yf_tkr_LLY |
| 2026-10-24 | Eli Lilly's Next-Generation Ovarian Cancer Drug Shows 79% Response Rate, 100% Disease Control In New Data · yf_tkr_LLY |
| 2026-10-24 | fda approved weight loss drug from eli lilly · BusinessWorld Online |
| 2026-10-24 | Eli Lilly, Novo Nordisk Antitrust Suit Remains Dismissed · Law360 |
| 2026-10-24 | Earnings Preview: LLY to Report Financial Results on October 29 · Moomoo |
| 2026-10-24 | Q2 earnings highs and lows: Eli Lilly (NYSE:LLY) vs the rest of the branded pharmaceuticals stocks · yf_tkr_LLY |
How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.
Open Fortivio.AI →Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。